NO20090358L - Retinoid-induserbar faktor, og anvendelse derav - Google Patents

Retinoid-induserbar faktor, og anvendelse derav

Info

Publication number
NO20090358L
NO20090358L NO20090358A NO20090358A NO20090358L NO 20090358 L NO20090358 L NO 20090358L NO 20090358 A NO20090358 A NO 20090358A NO 20090358 A NO20090358 A NO 20090358A NO 20090358 L NO20090358 L NO 20090358L
Authority
NO
Norway
Prior art keywords
inducible factor
retinoid
retinoid inducible
nucleic acid
various diseases
Prior art date
Application number
NO20090358A
Other languages
English (en)
Inventor
Johan R Lillehaug
Frederic Pendino
Original Assignee
Bergen Teknologioverforing As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bergen Teknologioverforing As filed Critical Bergen Teknologioverforing As
Priority to NO20090358A priority Critical patent/NO20090358L/no
Priority to PCT/NO2009/000214 priority patent/WO2009151337A2/en
Priority to US12/997,034 priority patent/US20120003181A1/en
Priority to EP09762718.6A priority patent/EP2321343B1/en
Priority to JP2011513442A priority patent/JP5797554B2/ja
Priority to ES09762718.6T priority patent/ES2542866T3/es
Priority to DK09762718.6T priority patent/DK2321343T3/en
Priority to ES09806059.3T priority patent/ES2546089T3/es
Priority to US13/145,859 priority patent/US9512484B2/en
Priority to EP09806059.3A priority patent/EP2389450B1/en
Priority to PCT/NO2009/000423 priority patent/WO2010085153A1/en
Publication of NO20090358L publication Critical patent/NO20090358L/no
Priority to NO20100815A priority patent/NO20100815A1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives en ny retinoid-responsiv nukleinsyre, og et nytt protein. Videre, oppfinnelsen beskriver anvendelse av en slik nukleinsyre eller protein i forskjellige sykdommer, og for behandling, diagnose og prognose av forskjellige sykdommer, og også en fremgangsmåte for prognose av responsivitet til retinoider.
NO20090358A 2008-06-09 2009-01-23 Retinoid-induserbar faktor, og anvendelse derav NO20090358L (no)

Priority Applications (12)

Application Number Priority Date Filing Date Title
NO20090358A NO20090358L (no) 2008-06-09 2009-01-23 Retinoid-induserbar faktor, og anvendelse derav
ES09762718.6T ES2542866T3 (es) 2008-06-09 2009-06-09 Factor inducible por retinoides novedoso y usos del mismo
US12/997,034 US20120003181A1 (en) 2008-06-09 2009-06-09 Novel Retinoid Inducible Factor and Uses Thereof
EP09762718.6A EP2321343B1 (en) 2008-06-09 2009-06-09 Novel retinoid inducible factor and uses thereof
JP2011513442A JP5797554B2 (ja) 2008-06-09 2009-06-09 新規レチノイド誘導因子およびその使用
PCT/NO2009/000214 WO2009151337A2 (en) 2008-06-09 2009-06-09 Novel retinoid inducible factor and uses thereof
DK09762718.6T DK2321343T3 (en) 2008-06-09 2009-06-09 New retinoidinducerbar factor and uses thereof
ES09806059.3T ES2546089T3 (es) 2009-01-23 2009-12-08 Métodos para determinar un pronóstico de supervivencia para una paciente con cáncer de mama
US13/145,859 US9512484B2 (en) 2009-01-23 2009-12-08 Methods for determining a prognosis for survival for a patient with breast cancer
EP09806059.3A EP2389450B1 (en) 2009-01-23 2009-12-08 Methods for determining a prognosis for survival for a patient with breast cancer
PCT/NO2009/000423 WO2010085153A1 (en) 2009-01-23 2009-12-08 Methods for determining a prognosis for survival for a patient with breast cancer
NO20100815A NO20100815A1 (no) 2008-06-09 2010-06-04 Novel retinoid inducible factor and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20082550 2008-06-09
NO20090358A NO20090358L (no) 2008-06-09 2009-01-23 Retinoid-induserbar faktor, og anvendelse derav

Publications (1)

Publication Number Publication Date
NO20090358L true NO20090358L (no) 2009-12-10

Family

ID=41328567

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20090358A NO20090358L (no) 2008-06-09 2009-01-23 Retinoid-induserbar faktor, og anvendelse derav
NO20100815A NO20100815A1 (no) 2008-06-09 2010-06-04 Novel retinoid inducible factor and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20100815A NO20100815A1 (no) 2008-06-09 2010-06-04 Novel retinoid inducible factor and uses thereof

Country Status (7)

Country Link
US (1) US20120003181A1 (no)
EP (1) EP2321343B1 (no)
JP (1) JP5797554B2 (no)
DK (1) DK2321343T3 (no)
ES (1) ES2542866T3 (no)
NO (2) NO20090358L (no)
WO (1) WO2009151337A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2616540T3 (es) 2010-07-21 2017-06-13 Bergen Teknologioverføring As Métodos para determinar un pronóstico de supervivencia para un paciente con leucemia
KR101721028B1 (ko) * 2014-02-12 2017-03-29 연세대학교 산학협력단 상처 치유 촉진용 조성물
WO2024074713A1 (en) * 2022-10-07 2024-04-11 Institut National de la Santé et de la Recherche Médicale Method to generate improving car-t cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527089A (ja) * 1999-08-17 2003-09-16 インサイト・ゲノミックス・インコーポレイテッド 膜関連タンパク質
EP1938104A2 (en) * 2005-10-17 2008-07-02 Institute for Systems Biology Tissue-and serum-derived glycoproteins and methods of their use

Also Published As

Publication number Publication date
WO2009151337A2 (en) 2009-12-17
NO20100815A1 (no) 2011-03-09
JP5797554B2 (ja) 2015-10-21
JP2011525352A (ja) 2011-09-22
EP2321343A2 (en) 2011-05-18
DK2321343T3 (en) 2015-08-24
ES2542866T3 (es) 2015-08-12
EP2321343B1 (en) 2015-06-03
WO2009151337A3 (en) 2010-07-08
US20120003181A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
WO2012018535A3 (en) Wellness panel
MX2015016047A (es) Metodo y sistema para mantener o mejorar el bienestar.
DK1597391T3 (da) Anvendelse af intron-RNA til måling af genekspression
WO2007047408A3 (en) Promac signature application
AR088827A1 (es) Metodos para tratar, diagnosticar, y monitorear la enfermedad de alzheimer
WO2015176066A3 (en) Lpa-associated protein and rna expression
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
WO2012076553A3 (en) Biomarkers and parameters for hypertensive disorders of pregnancy
ATE542903T1 (de) Luciferase-biosensoren für camp
DK3282250T3 (da) Elektrokemisk sensor til bestemmelse af en analytkoncentration
WO2011156734A3 (en) Method of characterizing vascular diseases
DE602005008146D1 (de) Methode für die Quantifizierung der Ausgangs-Konzentration von Nukleinsäuren ausgehend von real-time Amplifikationsdaten
ATE554389T1 (de) Apex als marker für lungenkrebs
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
WO2015034886A3 (en) Wellness panel for companion animals
WO2012050365A3 (ko) 교모세포종의 진단 또는 예후 예측용 바이오 마커 및 그 용도
EA201100582A1 (ru) Система бассейнов для рыбы (варианты), измерительное устройство для системы бассейнов и способ контроля бассейнов
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови
PL3634907T3 (pl) Modyfikowana węglowa matryca nanostrukturalna, zawierający taką matrycę układ i obejmujący taki układ biosensor oraz sposób oznaczania analitu w próbce z zastosowaniem układu biosensora jak również zastosowanie pochodnej kwasu benzopirolowego do modyfikowania węglowej matrycy nanostrukturalnej
WO2015054700A3 (en) Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof
ATE532868T1 (de) Apoptose induzierende positivkontrolle für expressionsmodulationsexperimente
NO20090358L (no) Retinoid-induserbar faktor, og anvendelse derav
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
WO2011051805A8 (en) Methods and systems for identifying molecules or processes of biological interest by using knowledge discovery in biological data
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application